As of October 8, 2026, Amanita muscaria / Muscimol is legal to sell at retail in Wisconsin. Not named on Wisconsin schedules or in any state law; edibles reachable only via general food-adulteration law. Controlling source: Wis. Stat. ch. 961 (2023-24 Wis. Stats., certified Oct. 1, 2026).
Verified October 8, 2026 · confidence: confirmedNothing in Wis. Stat. Sec. 961.14 (Schedule I) names Amanita muscaria, muscimol, or ibotenic acid (official text fetched 2026-10-07; psilocybin is listed, these are not). No Wisconsin statute or rule names these compounds, so the only reach is general food adulteration law read with FDA's Dec. 18, 2024 determination that A. muscaria and its constituents are unapproved food additives, which does not reach inhaled products such as vapes. Analogue-act reach is remote because muscimol and ibotenic acid are not structurally similar to any Schedule I or II hallucinogen.
Among Wisconsin's 4 neighbors, Illinois, Iowa, Michigan and Minnesota are legal, the same posture as Wisconsin.
Open the interactive map · Every compound in Wisconsin
Federal gray area. Not federally scheduled; FDA says A. muscaria, muscimol, ibotenic acid are unapproved food additives, unsafe in food. Federal detail
2 instruments on file for this compound's framework in Wisconsin; 3 of 3 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
3a1ed7bf79fb18f5**§ 961.14(4) (hallucinogen chapeau)** — "(4) Hallucinogenic substances. Any material, compound, mixture or preparation which contains any quantity of any of the following hallucinogenic substances, including any of their salts, isomers, esters, ethers, and salts of isomers, esters, or ethers that are theoretically possible within the specific chemical designation, in any form contained in a plant, obtained from a plant, or chemically synthesized:" — Wis. Stat. § 961.14(4), https://docs.legis.wisconsin.gov/document/statutes/961.14(4) (OFFICIAL — Wisconsin Legislature). Psilocin (s) and Psilocybin (r) are listed; 4-HO-MET is not, and there is no substituted-tryptamine class. **§ 961.01(12g) (isomer definition — narrows the catch-all)** — "'Isomer' means an optical isomer, but … in ss. 961.14(2)(nd) and (4) and 961.18(2m) 'isomer' includes any positional or geometric isomer." — Wis. Stat. § 961.01(12g), https://codes.findlaw.com/wi/controlled-substances-ch-961/wi-st-961-01/ (MIRROR: FindLaw). A homolog is neither positional nor geometric, so 4-HO-MET falls outside the class. **§ 961.01(4m)(a) (controlled substance analog)** — "'Controlled substance analog' means a substance the chemical structure of which is substantially similar to the chemical structure of a controlled substance included in schedule I or II and: 1. Which has a stimulant, depressant, narcotic or hallucinogenic effect on the central nervous system substantially similar to … a controlled substance included in schedule I or II; or 2. With respect to a particular individual, which the individual represents or intends to have [such effect] …" — Wis. Stat. § 961.01(4m)(a), https://codes.findlaw.com/wi/controlled-substances-ch-961/wi-st-961-01/ (MIRROR: FindLaw).
0a7fd287ab38c917961.25 Controlled substance analog treated as a schedule I substance. A controlled substance analog, to the extent it is intended for human consumption, shall be treated, for the purposes of this chapter, as a substance included in schedule I, unless a different treatment is specifically provided. No later than 60 days after the commencement of a prosecution concerning a controlled substance analog, the district attorney shall provide the controlled substances board with information relevant to emergency scheduling under s. 961.11 (4m). After a final determination by the controlled substances board that the controlled substance analog should not be scheduled, no prosecution relating to that substance as a controlled substance analog may be commenced or continued. 961.01 (4m) (a) "Controlled substance analog" means a substance the chemical structure of which is substantially similar to the chemical structure of a controlled substance included in schedule I or II and: 1. Which has a stimulant, depressant, narcotic or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant, narcotic or hallucinogenic effect on the central nervous system of a controlled substance included in schedule I or II; or 2. With respect to a particular individual, which the individual represents or intends to have a stimulant, depressant, narcotic or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant, narcotic or hallucinogenic effect on the central nervous system of a controlled substance included in schedule I or II.
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap